Things to Know About COVID-19 Vaccination Following Johnson & Johnson’s EUA 

  1. The U.S. Food and Drug Administration (FDA) has now approved three COVID-19 vaccines for Emergency Use Authorization (EUA). It is the first single-dose vaccine approved for EUA. 
  2. Johnson & Johnson’s single-dose vaccine uses a harmless adenovirus to activate an immune response to the coronavirus spike protein. It shows mild side effects like other vaccines. 
  3. Clinical trials showed a 72 percent efficacy against COVID-19 infection and 86 percent efficacy against severe illness and death in those who received the vaccine. No COVID-19 deaths were reported in those vaccinated during clinical trials. 
  4. It doesn’t matter which vaccine you receive. The most important thing is to get vaccinated when it is your turn. Vaccination is the most effective way to end the COVID-19 pandemic and protect yourself and those you come in contact with. 
  5. As health care professionals, we have the responsibility to continue to be leaders in our communities. Please encourage everyone to get educated about the vaccine’s safety and get vaccinated when supplies are available to them. Also, remind the people in your life of the importance of wearing with a mask, washing hands often, avoiding crowds and staying at least 6 feet away from others.